ferric citrate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4538 3522-50-7

Description:

MoleculeDescription

Synonyms:

  • fexeric
  • ferric citrate hydrate
  • ferric citrate
  • ferric citrate trihydrate
  • Molecular weight: 244.94
  • Formula: C6H5FeO7
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 99.13
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
6 g O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

DateAgencyCompanyOrphan
March 23, 2021 PMDA Japan Tobacco Inc.
Sept. 5, 2014 FDA KERYX BIOPHARMS

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC V03AE08 VARIOUS
ALL OTHER THERAPEUTIC PRODUCTS
ALL OTHER THERAPEUTIC PRODUCTS
Drugs for treatment of hyperkalemia and hyperphosphatemia
CHEBI has role CHEBI:75835 anti-anaemic agent

Related Drugs by ATC class:

V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia 10 drugs
calcium acetatecalcium acetate and magnesium carbonatecalcium polystyrene sulfonatecolestilanlanthanum carbonatepatiromer calciumsevelamersodium polystyrene sulfonatesodium zirconium cyclosilicatesucroferric oxyhydroxide

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hyperphosphatemia indication 20165001 DOID:0050459
Iron deficiency anemia indication 87522002




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
EQ 210MG IRON AURYXIA KERYX BIOPHARMS N205874 Sept. 5, 2014 RX TABLET ORAL 8093423 April 21, 2026 CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON AURYXIA KERYX BIOPHARMS N205874 Sept. 5, 2014 RX TABLET ORAL 10300039 July 21, 2030 CONTROL OF SERUM PHOSPHORUS LEVELS

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D09993 KEGG_DRUG
4033763 VUID
N0000191091 NUI
4033763 VANDF
CHEBI:144421 CHEBI
CHEMBL3301597 ChEMBL_ID
C025314 MESH_SUPPLEMENTAL_RECORD_UI
DB14520 DRUGBANK_ID
1594675 RXNORM
30829 MMSL
393541 MMSL
d08336 MMSL
007462 NDDF
763035003 SNOMEDCT_US
764380003 SNOMEDCT_US
C0060231 UMLSCUI
61300 PUBCHEM_CID
17217-76-4 SECONDARY_CAS_RN
756B6D74H4 UNII

Pharmaceutical products:

None